Programme Coordinator at EUPATI
Matthew holds of Masters in Chemistry from the University of Edinburgh. He briefly worked in drug discovery and drug delivery systems development labs in Switzerland, and in biodiversity population studies in Madagascar before joining the European Patients Academy on Therapeutic Innovation (EUPATI) project as content development project manager. During the IMI-project Matthew chaired the editorial board which reviews all educational content that EUPATI produces, and worked on the EUPATI Guidance documents for patient involvement in medicines R&D. In April 2017 he became Coordinator of the post-IMI EUPATI Programme hosted by EPF and continues to work on multi-stakeholder patient engagement projects such as IMI-PARADIGM, and IMI-EFOEUPATI.
1 blog from the author
Posted on 03.10.2019
The European Patients’ Academy (EUPATI) has trained dozens of patients to engage with companies and decision-makers on medicines development. Now it’s time to think about medtech. I am convinced that the days when experts and clinicians decided what patients want are long gone. Modern healthcare aspires to be patient-centred, while academics, policymakers and industry are […]